FEG
AXNX icon

Financial Enhancement Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Financial Enhancement Group’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,797
Closed -$1.08M – 285
2020
Q2 		$1.08M Buy
+30,797
New +$1.06M 0.27% 53

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Waddell & Reed Financial
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Polar Capital
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Financial Enhancement Group's AXNX Position: Q3 2020 in Review

Financial Enhancement Group sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2020, closing a stake of 30,797 shares — an estimated $1.08M sold.

Financial Enhancement Group first reported a position in AXNX in Q2 2020 and held it in 1 quarter. The position peaked at $1.08M in Q2 2020. 151 funds tracked by Wall St. Rank hold AXNX as of Q3 2020.

  • Financial Enhancement Group reported no remaining Axonics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Financial Enhancement Group sold 30,797 Axonics, Inc. Common Stock shares in Q3 2020, an estimated $1.08M.
  • Financial Enhancement Group first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Financial Enhancement Group's Axonics, Inc. Common Stock position peaked at $1.08M in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2020.

Based on Financial Enhancement Group's 13F filing for Q3 2020, filed 18 Nov 2020.